Zhonghua Tao

ORCID：0000-0003-3975-3803

发表论文 132 篇 · 总被引 1721 次 · h-index 25

代表论文

• Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor–Positive and ERBB2 -Negative Advanced Breast Cancer After Endocrine Therapy (2025 · JAMA Oncology · 被引 4)
• A phase II clinical study of adebrelimab and bevacizumab combined with cisplatin/carboplatin in triple-negative breast cancer patients with brain metastases. (2025 · Journal of Clinical Oncology · 被引 3)
• Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy (2025 · Precision Clinical Medicine · 被引 2)
• Reciprocal stabilization of CtBP and TRIM28 represses autophagy to promote metastasis (2025 · Nature Structural & Molecular Biology · 被引 2)
• Ferroptosis-related genes as prognostic markers for survival and immunotherapy in triple-negative breast cancer: analysis of public databases and a single institution (2025 · Therapeutic Advances in Medical Oncology · 被引 2)
• Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China (2025 · EClinicalMedicine · 被引 1)